These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26915605)

  • 1. A Randomized, Placebo-Controlled, Double-Blind Efficacy Study of Nefiracetam to Treat Poststroke Apathy.
    Starkstein SE; Brockman S; Hatch KK; Bruce DG; Almeida OP; Davis WA; Robinson RG
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1119-1127. PubMed ID: 26915605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind treatment of apathy in patients with poststroke depression using nefiracetam.
    Robinson RG; Jorge RE; Clarence-Smith K; Starkstein S
    J Neuropsychiatry Clin Neurosci; 2009; 21(2):144-51. PubMed ID: 19622685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind randomized treatment of poststroke depression using nefiracetam.
    Robinson RG; Jorge RE; Clarence-Smith K
    J Neuropsychiatry Clin Neurosci; 2008; 20(2):178-84. PubMed ID: 18451188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
    Thobois S; Lhommée E; Klinger H; Ardouin C; Schmitt E; Bichon A; Kistner A; Castrioto A; Xie J; Fraix V; Pelissier P; Chabardes S; Mertens P; Quesada JL; Bosson JL; Pollak P; Broussolle E; Krack P
    Brain; 2013 May; 136(Pt 5):1568-77. PubMed ID: 23543483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apathy following stroke.
    Jorge RE; Starkstein SE; Robinson RG
    Can J Psychiatry; 2010 Jun; 55(6):350-4. PubMed ID: 20540829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
    Guekht AB; Moessler H; Novak PH; Gusev EI;
    J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian sleep/wake rhythm abnormalities as a risk factor of a poststroke apathy.
    Cosin C; Sibon I; Poli M; Allard M; Debruxelles S; Renou P; Rouanet F; Mayo W
    Int J Stroke; 2015 Jul; 10(5):710-5. PubMed ID: 25545189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease.
    Frakey LL; Salloway S; Buelow M; Malloy P
    J Clin Psychiatry; 2012 Jun; 73(6):796-801. PubMed ID: 22687392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient improvement of poststroke apathy with zolpidem: a single-case, placebo-controlled double-blind study.
    Autret K; Arnould A; Mathieu S; Azouvi P
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23396925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
    Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
    Trials; 2015 Dec; 16():561. PubMed ID: 26654631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
    Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial.
    Gelderblom H; Wüstenberg T; McLean T; Mütze L; Fischer W; Saft C; Hoffmann R; Süssmuth S; Schlattmann P; van Duijn E; Landwehrmeyer B; Priller J
    PLoS One; 2017; 12(3):e0173872. PubMed ID: 28323838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of the traditional chinese medicine Neuroaid (MLC 601) in enhancing recovery after stroke (TIERS).
    Kong KH; Wee SK; Ng CY; Chua K; Chan KF; Venketasubramanian N; Chen C
    Cerebrovasc Dis; 2009; 28(5):514-21. PubMed ID: 19816018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
    Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G;
    JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil May Alleviate Poststroke Fatigue: A Randomized, Placebo-Controlled, Double-Blinded Trial.
    Poulsen MB; Damgaard B; Zerahn B; Overgaard K; Rasmussen RS
    Stroke; 2015 Dec; 46(12):3470-7. PubMed ID: 26534969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nefiracetam. DM 9384, DZL 221, Translon.
    Drugs R D; 1999 Aug; 2(2):137-41. PubMed ID: 10820661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.